๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Biliary Tract Cancer

A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 Personalized Medicine for Advanced Biliary Cancer Patients NCT05615818Phase 369 sites๐Ÿ“ Brussels๐Ÿ“ Brussels๐Ÿ“ Edegem UNICANCER ยท Tests: Futibatinib, Ivosidenib, Zanidatamab, Trastuzumab, Neratinib AB122 Platform Study NCT04999761Phase 19 sites๐Ÿ“ Aichi๐Ÿ“ Chiba๐Ÿ“ Ehime Taiho Pharmaceutical Co., Ltd. ยท Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: CEA-targeted CAR-T cells Study of TU2218 in Combination With KEYTRUDAยฎ(Pembrolizumab) in Patients With Advanced Solid Tumors NCT05784688Phase 1, Phase 211 sites๐Ÿ“ San Antonio๐Ÿ“ Tyler๐Ÿ“ Spokane TiumBio Co., Ltd. ยท Tests: TU2218 + KEYTRUDAยฎ (Pembrolizumab) Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma NCT05874414Phase 1, Phase 211 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Orlando Genfit ยท Tests: GNS561 + Trametinib Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer NCT07636798Phase 1, Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: HAIC Combined Regimen Treatment Group Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer NCT07025174Phase 21 site๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: PD-1/CTLA-4 Dual Functional Antibody, Gemcitabine, Cisplatin, Anlotinib, Oxaliplatin + 5-Fluorouracil/Leucovorin Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors NCT06975410Phase 1, Phase 24 sites๐Ÿ“ Seoul๐Ÿ“ Seoul๐Ÿ“ Seoul Yuhan Corporation ยท Tests: YH32364 Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients NCT07062263Phase 36 sites๐Ÿ“ Muzaffarpur๐Ÿ“ Mumbai๐Ÿ“ Bhubaneswar Tata Memorial Centre ยท Tests: Trastuzumab, Chemotherapy Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer NCT07704177Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Trastuzumab Rezetecan, Adebrelimab, Lenvatinib Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) NCT04611867NA1 site๐Ÿ“ Herlev Inna Chen, MD ยท Tests: Supportive application with integrated weekly PRO A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site๐Ÿ“ Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-8989 Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors NCT04900818Phase 121 sites๐Ÿ“ Orange๐Ÿ“ Aurora๐Ÿ“ Layfayette I-Mab Biopharma US Limited ยท Tests: TJ033721 (givastomig), TJ033721 (givastomig) , nivolumab, chemotherapy, TJ033721 (givastomig), chemotherapy, TJ033721 (โ€ฆ A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 NCT07186842Phase 1, Phase 218 sites๐Ÿ“ Denver๐Ÿ“ Orlando๐Ÿ“ Detroit BioNTech SE ยท Tests: BNT329, CA19-9-targeting monoclonal antibody Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer NCT07641036Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-HC01 dual-target CARNK cells, Fludarabine, Cyclophosphamide A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain NCT07326137n/a1 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: First-Line Systemic Therapy, Celiac Plexus Neurolysis (CPN) Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma NCT07099547Phase 21 site๐Ÿ“ Hefei Suzhou Zelgen Biopharmaceuticals Co.,Ltd ยท Tests: ZG005, Tislelizumab, Gemcitabine, Cisplatin HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours NCT06708663Phase 1, Phase 21 site๐Ÿ“ Beijing Hangzhou Hanx Biopharmaceuticals, Ltd. ยท Tests: HX009+IN10018 mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line NCT07062536Phase 211 sites๐Ÿ“ Busan๐Ÿ“ Daegu๐Ÿ“ Gangneung Seoul National University Bundang Hospital ยท Tests: Oxaliplatin, 5FU, leucovorin, Oxaliplatin, 5FU, leucovorin/Irinotecan , 5FU, leucovorin, A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation NCT07458347Phase 19 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ Tampa Kestrel Therapeutics, Inc. ยท Tests: KST-6051, Gemcitabine/nab-paclitaxel, Cetuximab, Pembrolizumab, mFOLFOX6 Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer NCT06230471Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Pembrolizumab,Lenvatinib and Gemox Chemotherapy๏ผˆGemcitabine and Oxaliplatin๏ผ‰, Pembrolizumab and Lenvatinib, Pembrolizumโ€ฆ A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure NCT07606599Phase 32 sites๐Ÿ“ Hefei๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M07D1, Oxaliplatin, Calcium levofolinate, Fluorouracil, Irinotecan Hydrochloride Liposome Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB) NCT06712420Phase 33 sites๐Ÿ“ Delhi๐Ÿ“ Delhi๐Ÿ“ Delhi Rajiv Gandhi Cancer Institute & Research Center, India ยท Tests: neoadjuvant chemotherapy, curative surgery Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC NCT05733598Phase 212 sites๐Ÿ“ Beverly Hills๐Ÿ“ La Jolla๐Ÿ“ Miami Replimune, Inc. ยท Tests: RP2, Bevacizumab, Atezolizumab, Durvalumab, RP2 Monotherapy GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment ๏ผˆBTC-IM-1๏ผ‰ NCT06988592n/a1 site๐Ÿ“ Shanghai Fudan University ยท Tests: GemCis plus PD-1/PD-L1 inhibitor CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors NCT06937567EARLY Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: CDH17 CAR-T, FAST LACO-Stim CDH17 CAR-T A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer NCT06431490Phase 1, Phase 243 sites๐Ÿ“ Fuyang๐Ÿ“ Hefei๐Ÿ“ Hefei Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharโ€ฆ ยท Tests: TQB2102 for injection A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies NCT05123482Phase 1, Phase 267 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Santa Monica AstraZeneca ยท Tests: AZD8205, AZD8205 and AZD2936 (Rilvegostomig), AZD8205 and AZD5305 (saruparib), AZD8205 and AZD5305 (saruparib) and AZD2โ€ฆ Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer NCT07710885Phase 321 sites๐Ÿ“ Brisbane๐Ÿ“ Melbourne๐Ÿ“ Perth Taiho Pharmaceutical Co., Ltd. ยท Tests: Futibatinib, Zimberelimab, Durvalumab, Pembrolizumab, Gemcitabine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy